Italfarmaco Sa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ITALFARMACO SA
ITALFARMACO SA has one approved drug.
There is one US patent protecting ITALFARMACO SA drugs.
Summary for Italfarmaco Sa
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Italfarmaco Sa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Italfarmaco Sa | TIGLUTIK KIT | riluzole | SUSPENSION;ORAL | 209080-001 | Sep 5, 2018 | AB | RX | Yes | Yes | 8,765,150 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Italfarmaco Sa Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2228054 | ⤷ Start Trial |
| Cyprus | 1113825 | ⤷ Start Trial |
| South Korea | 101680175 | ⤷ Start Trial |
| Hong Kong | 1161985 | ⤷ Start Trial |
| Canada | 2748856 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
